Alexis Borisy
Fondatore presso RELAY THERAPEUTICS, INC.
Patrimonio netto: 110 M $ in data 31/01/2025
Profilo
Fondatore di 5 diverse aziende, in particolare: Blueprint Medicines Corp., Foundation Medicine, Inc. e Relay Therapeutics, Inc. Alexis A. Borisy è un imprenditore e uomo d'affari che è stato a capo di 10 diverse aziende e ricopre la posizione di presidente esecutivo per Relay Therapeutics, Inc. (che ha fondato nel 2015), presidente di Tango Therapeutics, Inc., presidente di Celsius Therapeutics, Inc., presidente e amministratore delegato di Eqrx, Inc. e partner di Third Rock Ventures LLC. Alexis A. Borisy è anche nel consiglio di amministrazione di altre 6 società. Il sig. Borisy è stato precedentemente presidente di FORMA Therapeutics, Inc. (ha fondato la società nel 2007), direttore presso la National Venture Capital Association, direttore indipendente presso Foundation Medicine, Inc. (ha fondato la società nel 2009), presidente esecutivo di Warp Drive Bio, Inc. e presidente, amministratore delegato e direttore di CombinatoRx, Inc. (ha fondato la società nel 2000). Alexis A. Borisy ha conseguito una laurea presso l'Università di Chicago e una laurea presso la Harvard University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
20/06/2024 | 2 335 742 ( 1,28% ) | 100 M $ | 31/01/2025 | |
12/06/2024 | 74 160 ( 0,12% ) | 8 M $ | 31/01/2025 | |
RELAY THERAPEUTICS, INC.
0,14% | 03/06/2024 | 234 175 ( 0,14% ) | 1 M $ | 31/01/2025 |
OPKO HEALTH, INC.
0,05% | 29/02/2024 | 312 612 ( 0,05% ) | 475 170 $ | 31/01/2025 |
TANGO THERAPEUTICS, INC.
0,01% | 05/06/2024 | 11 250 ( 0,01% ) | 33 525 $ | 31/01/2025 |
Ultime notizie su Alexis Borisy
Posizioni attive di Alexis Borisy
Società | Posizione | Inizio |
---|---|---|
BLUEPRINT MEDICINES CORPORATION | Fondatore | 01/10/2008 |
REVOLUTION MEDICINES, INC. | Direttore/Membro del Consiglio | 01/11/2014 |
RELAY THERAPEUTICS, INC. | Fondatore | 04/05/2015 |
TANGO THERAPEUTICS, INC. | Presidente | - |
Museum of Science
![]() Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Presidente | - |
Modex Therapeutics, Inc.
![]() Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The company is based in Weston, MA. The company was founded in 2020 by Alexis A. Borisy, Elias A. Zerhouni, Gary J. Nabel. Gary J. Nabel has been the CEO of the company since 2020. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Fondatore | 01/10/2020 |
EQRx International, Inc.
![]() EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Fondatore | 01/01/2020 |
Celsius Therapeutics, Inc.
![]() Celsius Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investitore di Private Equity | 22/12/2010 |
Precedenti posizioni note di Alexis Borisy
Società | Posizione | Fine |
---|---|---|
░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Alexis Borisy
The University of Chicago | Undergraduate Degree |
Harvard University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
EDITAS MEDICINE, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
RELAY THERAPEUTICS, INC. | Health Technology |
TANGO THERAPEUTICS, INC. | Health Technology |
OPKO HEALTH, INC. | Health Services |
Aziende private | 17 |
---|---|
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Foundation Medicine, Inc.
![]() Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in providing information on clinical treatment decisions for patients with cancer. The company was founded in November 2009 and is headquartered in Cambridge, MA. | Health Services |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
National Venture Capital Association
![]() National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
Warp Drive Bio, Inc.
![]() Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Health Technology |
Museum of Science
![]() Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Consumer Services |
Tango Therapeutics Sub, Inc.
![]() Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Celsius Therapeutics, Inc.
![]() Celsius Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Commercial Services |
Thrive Earlier Detection Corp.
![]() Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Health Technology |
EQRx International, Inc.
![]() EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Health Technology |
Dascena, Inc.
![]() Dascena, Inc. Miscellaneous Commercial ServicesCommercial Services Dascena, Inc. develops machine learning algorithms to enable early disease intervention. The company was founded by Ritankar Das and is headquartered in Oakland, CA. | Commercial Services |
EQRx, Inc.
![]() EQRx, Inc. Pharmaceuticals: MajorHealth Technology EQRx, Inc. is a pharmaceutical company, which engages in developing and delivering innovative medicines to patients having chronic conditions. The company was founded by Alexis A. Borisy, Sandra J. Horning, Robert M. Forrester, Peter Bach, and Melanie I. Nallicheri on August 26, 2019 and is headquartered in Cambridge, MA. | Health Technology |
Modex Therapeutics, Inc.
![]() Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The company is based in Weston, MA. The company was founded in 2020 by Alexis A. Borisy, Elias A. Zerhouni, Gary J. Nabel. Gary J. Nabel has been the CEO of the company since 2020. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Commercial Services |
Magenta Therapeutics, Inc.
![]() Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
IDRx, Inc.
![]() IDRx, Inc. BiotechnologyHealth Technology IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Alexis Borisy